Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Total Non-Current Liabilities (2020 - 2025)

Rapid Micro Biosystems' Total Non-Current Liabilities history spans 6 years, with the latest figure at $39.7 million for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 87.51% year-over-year to $39.7 million; the TTM value through Sep 2025 reached $39.7 million, up 87.51%, while the annual FY2024 figure was $22.8 million, 9.46% down from the prior year.
  • Total Non-Current Liabilities for Q3 2025 was $39.7 million at Rapid Micro Biosystems, up from $20.7 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $135.5 million in Q1 2021 and bottomed at -$179.2 million in Q3 2022.
  • The 5-year median for Total Non-Current Liabilities is $21.2 million (2024), against an average of $3.2 million.
  • The largest annual shift saw Total Non-Current Liabilities plummeted 1071.58% in 2022 before it surged 118.49% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $19.0 million in 2021, then soared by 38.32% to $26.3 million in 2022, then fell by 4.01% to $25.2 million in 2023, then fell by 9.46% to $22.8 million in 2024, then skyrocketed by 74.07% to $39.7 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Total Non-Current Liabilities are $39.7 million (Q3 2025), $20.7 million (Q2 2025), and $19.6 million (Q1 2025).